Table 1 Different conditions for 3′-phosphorylation of trinucleotides
2-cyanoethyl-N,N,N′,N′-tetraisopropylphosphordiamidite requires
activation by tetrazole derivatives, and the reaction is not depen-
dent on the presence of strong bases. According to the original
protocol,23 diisopropylammonium tetrazolide is used for acti-
vation of 2-cyanoethyl-N,N,N′,N′-tetraisopropylphosphordiami-
dite. Preparation of trinucleotide phosphoramidites following
this protocol, however, was again accompanied by significant
loss of the β-cyanoethyl group. Reaction of one equivalent of the
tetrazolide with one equivalent of the nucleotide produces two
equivalents diisopropylamine, which obviously is strong enough
to initiate β-elimination of the β-cyanoethyl group. In an attempt
to circumvent this problem, we replaced the tetrazolide with ben-
zylmercapto tetrazole (Table 1). This reaction produces only one
equivalent of diisopropyl amine, which is neutralized by the ben-
zylmercaptotetrazole released back after reaction. Since benzyl-
mercaptotatrazole is more strongly acidic than normal tetrazole
or ethylmercaptotetrazole,24 it acts as a perfect scavenger for di-
isopropyl amine converting it into the ammonium salt. Under
these conditions, preparation of phosphoramidites was most suc-
cessful; only traces of by-products could be detected. Following
this protocol, trinucleotide phosphoramidite synthons represent-
ing codons for all 20 amino acids were prepared. All trinucleo-
tides were successfully incorporated in short test oligo-
nucleotides (see ESI, Table S3†).
Phosphorylation
Entry reagent
Base
Activator
Yielda
n. d.
1
DIPEA
—
2
3
4
5
Pyridine
Lutidine
Collidine
—
—
—
—
n. d.
n. d.
n. d.
n. d.
The trinucleotide phosphoramidites presented here, are advan-
tageous over previously described trinucleotide synthons in
terms of quality and application. Due to the choice of a superior
3′-O-protecting group and their mild and efficient removal, no
by-products or isomeric di- and trimers were observed. Further-
more, using β-cyanoethyl as phosphate protecting group allows
for easy application of the trinucleotide phosphoramidites in
standard DNA synthesis without the need for specific protocols
during work-up and deprotection.
6
—
quantitative
a n. d.: not detectable
group. After oxidation of the phosphorous, however, it is crucial
to avoid contamination with strong bases. Cleavage of the
TBDMS group with TEAx3HF as described above is not proble-
matic, since the reagent is weakly acidic.22 According to the pro-
tocol used for 2′-O-deprotection of RNA, the reaction is
quenched by addition of water. This is not possible here, since
hydrolysis of the reagent results in a strongly acidic solution,
which would cleave off the DMT group. Therefore, we quenched
the reaction by addition of saturated bicarbonate solution with
stringent control of the pH, in order to keep neutral conditions
that leave the DMT group as well as the phosphate β-cyanoethyl
group intact. Following this procedure, 20 trinucleotides of high
purity were prepared (see ESI, Table S2†). The crucial step is the
following preparation of the trinucleotide phosphoramidite
(Table 1). We have evaluated two different ways using either 2-
cyanoethyl-N,N-diisopropyl-chlorophosphoramidite or 2-cyano-
Notes and references
‡S. Müller, M. Janczyk. Verfahren zur Herstellung von Trinukleotiden,
DE102009046981.8, PCT/EP2010/06731.3.
1 T. S. Wong, D. Roccatano and U. Schwaneberg, Environ. Microbiol.,
2007, 9, 2645–2659.
2 S. Sen, V. V. Dasu and B. Mandal, Appl. Biochem. Biotechnol., 2007,
143, 212–223.
3 N. E. Labrou, Curr. Protein Pept. Sci., 2010, 11, 91–100.
4 R. A. M. Hooft von Huijsduijnen, G. Ayala and J. F. DeLamater, Nucleic
Acids Res., 1992, 20, 919.
5 R. C. Cadwell and G. F. Joyce, PCR Methods Appl., 1992, 2, 28.
6 W. P. Stemmer, Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 10747.
7 K. M. Derbyshire, J. J. Salvo and N. D. F. Grindley, Gene, 1986, 46, 145.
8 J. Sondek and D. Shortle, Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 3581.
9 B. Virnekäs, L. Ge, A. Plückthun, K. C. Schneider, G. Wellnhofer and S.
E. Moroney, Nucleic Acids Res., 1994, 22, 5600.
10 M. H. Lyttle, E. W. Napolitano, B. L. Calio and L. M. Kauvar, BioTechni-
ques, 1995, 19, 274.
ethyl-N,N,N′,N′-tetraisopropylphosphordiamidite (Table
1).
11 A. Ono, A. Matsuda, J. Zhao and D. V. Santi, Nucleic Acids Res., 1995,
23, 4677.
12 A. L. Kayushin, M. D. Korosteleva, A. I. Miroshnikov, W. Kosch,
D. Zubov and N. Piel, Nucleic Acids Res., 1996, 24, 3748.
13 A. Zehl, A. Starke, D. Cech, T. Hartsch, R. Merkl and H.-J. Fritz, Chem.
Commun., 1996, 2677.
14 P. Gaytán, J. Yanez, F. Sánchez, H. Mackie and X. Soberon, Chem. Biol.,
1998, 5, 519.
15 A. Kayushin, M. Korosteleva and A. Miroshnikov, Nucleosides, Nucleo-
tides Nucleic Acids, 2000, 19, 1967.
Using 2-cyanoethyl-N,N-diisopropyl-chlorophosphoramidite
requires the presence of DIPEA functioning as scavenger for
HCl, that is generated upon reaction. As expected, preparation of
phosphoramidites following this protocol led to removal of the
β-cyanoethyl group, as analyzed by TLC. Our attempts to
replace DIPEA with less strong bases such as pyridine, lutidine
or collidine (Table 1) failed. In these cases, no formation of the
phosphoramidite could be observed. The alternative reagent
1512 | Org. Biomol. Chem., 2012, 10, 1510–1513
This journal is © The Royal Society of Chemistry 2012